Episodes 1-15 of 247
Managing MCL After BTKi Failure: The Expanding Role of CAR T-Cell Therapy
Project Oncology®Managing MCL After BTKi Failure: The Expanding Role of CAR T-Cell Therapy
Managing Genotype-Positive Patients in Hereditary ATTR-CM
On the Frontlines of ATTR-CMManaging Genotype-Positive Patients in Hereditary ATTR-CM
Chronic Graft-Versus-Host Disease Care: Evolving Therapeutic Strategies
Project Oncology®Chronic Graft-Versus-Host Disease Care: Evolving Therapeutic Strategies
LUMINESCE: Assessing Satralizumab in Generalized Myasthenia Gravis
NeuroFrontiersLUMINESCE: Assessing Satralizumab in Generalized Myasthenia Gravis
Advancements in gMG Management: Zilucoplan as an Alternative to C5 Inhibitors
NeuroFrontiersAdvancements in gMG Management: Zilucoplan as an Alternative to C5 Inhibitors
Examining Inebilizumab in Generalized Myasthenia Gravis: Insights from MINT
NeuroFrontiersExamining Inebilizumab in Generalized Myasthenia Gravis: Insights from MINT
- advertisement
The Cost of Progress: Examining Barriers to ATTR-CM Care
On the Frontlines of ATTR-CMThe Cost of Progress: Examining Barriers to ATTR-CM Care
Evaluating Axatilimab in Chronic GVHD: How Prior Therapies Impact Outcomes
Project Oncology®Evaluating Axatilimab in Chronic GVHD: How Prior Therapies Impact Outcomes
Diagnostic Gaps in ATTR-CM: Insights from a Multispecialty Survey in France
Heart MattersDiagnostic Gaps in ATTR-CM: Insights from a Multispecialty Survey in France
ATTR-CM Care: Impact of Vutrisiran on Survival and Cardiovascular Events
Heart MattersATTR-CM Care: Impact of Vutrisiran on Survival and Cardiovascular Events
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Living RheumImproving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Vutrisiran for ATTR-CM: Impacts on Functional Capacity and Quality of Life
On the Frontlines of ATTR-CMVutrisiran for ATTR-CM: Impacts on Functional Capacity and Quality of Life
- advertisement
Saliva as a Window Into Cystic Fibrosis: Metabolic Biomarkers and Clinical Potential
Clinician's RoundtableSaliva as a Window Into Cystic Fibrosis: Metabolic Biomarkers and Clinical Potential
Advances in Disease-Modifying and Curative Therapies for Sickle Cell Disease
Project Oncology®Advances in Disease-Modifying and Curative Therapies for Sickle Cell Disease
CRISPR in Sickle Cell: Transforming Care Through Gene Editing
Project Oncology®CRISPR in Sickle Cell: Transforming Care Through Gene Editing
